Literature DB >> 3745433

Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.

A F Stalenhoef, M J Malloy, J P Kane, R J Havel.   

Abstract

The metabolism of apolipoproteins B-48 and B-100 (apo B-48 and B-100) in large triglyceride-rich lipoproteins was studied in three adults with familial dysbetalipoproteinemia (F. dys.) and compared to that of normolipidemic subjects. One Caucasian F. dys. subject was apparently homozygous for the common form of apo E-2, (Arg158----Cys), whereas the two Black subjects were homozygous for a different apo E-2 mutant (Arg145----Cys), which displays much less defective binding to cells than apo E-2 (Arg158----Cys). The lipoproteins were labeled with 125I and injected intravenously into fasted recipients. The results indicate that the terminal catabolism of triglyceride-rich lipoproteins of intestinal and hepatic origin is markedly impaired in apo E2/2 homozygotes with alleles Arg158----Cys and Arg145----Cys; despite long residence times, apo B-48 of chylomicrons and apo B-100 of large very low density lipoproteins are not converted appreciably to intermediate or low density lipoproteins in apo E2/2 homozygotes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3745433      PMCID: PMC423660          DOI: 10.1172/JCI112632

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Impaired very low density lipoprotein and triglyceride removal in broad beta disease: comparison with endogenous hypertriglyceridemia.

Authors:  A Chait; W R Hazzard; J J Albers; R P Kushwaha; J D Brunzell
Journal:  Metabolism       Date:  1978-09       Impact factor: 8.694

2.  Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects.

Authors:  M Berman; M Hall; R I Levy; S Eisenberg; D W Bilheimer; R D Phair; R H Goebel
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

3.  Fluorometric enzymatic determination of total cholesterol in serum.

Authors:  H Huang; J W Kauan; G G Guilbault
Journal:  Clin Chem       Date:  1975-10       Impact factor: 8.327

4.  The independent synthesis of intermediate density lipoproteins in type III hyperlipoproteinemia.

Authors:  M F Reardon; M E Poapst; G Steiner
Journal:  Metabolism       Date:  1982-05       Impact factor: 8.694

5.  Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.

Authors:  G Sigurdsson; A Nicoll; B Lewis
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

6.  Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans.

Authors:  T Sata; R J Havel; A L Jones
Journal:  J Lipid Res       Date:  1972-11       Impact factor: 5.922

7.  Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. An animal model of human familial hypercholesterolemia.

Authors:  R J Havel; T Kita; L Kotite; J P Kane; R L Hamilton; J L Goldstein; M S Brown
Journal:  Arteriosclerosis       Date:  1982 Nov-Dec

8.  Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.

Authors:  W J Schneider; P T Kovanen; M S Brown; J L Goldstein; G Utermann; W Weber; R J Havel; L Kotite; J P Kane; T L Innerarity; R W Mahley
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.

Authors:  C J Packard; A Munro; A R Lorimer; A M Gotto; J Shepherd
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia.

Authors:  R J Havel; Y Chao; E E Windler; L Kotite; L S Guo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

View more
  16 in total

Review 1.  Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids.

Authors:  Jacqueline de Graaf; Mario J Veerkamp; Anton F H Stalenhoef
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 2.  Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies.

Authors:  D C Chan; J Pang; G Romic; G F Watts
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

3.  Low density lipoprotein receptor-independent hepatic uptake of a synthetic, cholesterol-scavenging lipoprotein: implications for the treatment of receptor-deficient atherosclerosis.

Authors:  K J Williams; S Vallabhajosula; I U Rahman; T M Donnelly; T S Parker; M Weinrauch; S J Goldsmith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

4.  ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  J Lipid Res       Date:  2016-03-25       Impact factor: 5.922

5.  High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

6.  Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.

Authors:  Y A Kesäniemi; C Ehnholm; T A Miettinen
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

7.  Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.

Authors:  P de Knijff; A M van den Maagdenberg; D I Boomsma; A F Stalenhoef; A H Smelt; J J Kastelein; A D Marais; R R Frants; L M Havekes
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

Review 8.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef
Journal:  J Clin Endocrinol Metab       Date:  2012-09       Impact factor: 5.958

9.  Compositional changes and apoprotein A-I metabolism of plasma high density lipoprotein in estrogenized chicks.

Authors:  B H Cho; J R Park
Journal:  Lipids       Date:  1991-10       Impact factor: 1.880

10.  The effect of the apolipoprotein E polymorphism on lipid levels in patients with familial defective apolipoprotein B-100.

Authors:  C Manke; H Schuster; C Keller; G Wolfram
Journal:  Clin Investig       Date:  1993-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.